• Bombardier C, Hazlewood GS, Akhavan P, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety. J Rheumatol. 2012;39:1583–602.

    CAS 
    Article 

    Google Scholar
     

  • Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020;79:685–99.

    CAS 
    Article 

    Google Scholar
     

  • Singh JA, Saag KG, Bridges SL, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68:1–26.

    PubMed 

    Google Scholar
     

  • Fischer F, Lange K, Klose K, Greiner W, Kraemer A. Barriers and Strategies in Guideline Implementation-A Scoping Review. Healthcare (Basel) 2016;4.

  • Gagliardi AR, Alhabib S, members of Guidelines International Network Implementation Working G. Trends in guideline implementation: a scoping systematic review. Implement Sci 2015;10:54.

  • Sheldon TA, Cullum N, Dawson D, Lankshear A, Lowson K, Watt I, et al. What’s the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients’ notes, and interviews. BMJ. 2004;329:999.

    Article 

    Google Scholar
     

  • Michaud K, Pope J, van de Laar M, Curtis JR, Kannowski C, Mitchell S, et al. Systematic literature review of residual symptoms and an unmet need in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2021;73:1606–16.

    Article 

    Google Scholar
     

  • Doumen M, De Cock D, Pazmino S, Bertrand D, Joly J, Westhovens R, et al. Psychosocial burden predicts sustained remission in early rheumatoid arthritis: unraveling the complex interplay of wellbeing and disease activity. Arthritis Care Res (Hoboken) 2021.

  • Taylor PC, Van de Laar M, Laster A, Fakhouri W, Quebe A, de la Torre I, et al. Call for action: incorporating wellness practices into a holistic management plan for rheumatoid arthritis-going beyond treat to target. RMD Open 2021;7.

  • Schrijvers G, van Hoorn A, Huiskes N. The care pathway: concepts and theories: an introduction. Int J Integr Care 2012;12:e192.

  • Barber CEH, Spencer N, Bansback N, Zimmermann GL, Li LC, Richards DP, et al. Development of an implementation strategy for patient decision aids in rheumatoid arthritis through application of the behavior change wheel. ACR Open Rheumatol. 2021;3:312–23.

    Article 

    Google Scholar
     

  • Lawal AK, Rotter T, Kinsman L, Machotta A, Ronellenfitsch U, Scott SD, et al. What is a clinical pathway? Refinement of an operational definition to identify clinical pathway studies for a Cochrane systematic review. BMC Med. 2016;14:35.

    Article 

    Google Scholar
     

  • Lianes O, Nystad TW, Roen SA, Fevang BS. Structured patient care pathway for gout. Tidsskr Nor Laegeforen 2020;140.

  • Soto GE, Huenefeldt EA, Hengst MN, Reimer AJ, Samuel SK, Samuel SK, et al. Implementation and impact analysis of a transitional care pathway for patients presenting to the emergency department with cardiac-related complaints. BMC Health Serv Res. 2018;18:672.

    Article 

    Google Scholar
     

  • Ashraf H, Warren E, Latner JP, Shah KB, Bell J, Lowe S, et al. Effect of medication adherence and early follow-up on unplanned readmission post-myocardial infarction: quality improvement in a safety net hospital. Crit Pathw Cardiol. 2021;20:71–4.

    Article 

    Google Scholar
     

  • Connell A, Montgomery H, Martin P, Nightingale C, Sadeghi-Alavijeh O, King D, et al. Evaluation of a digitally-enabled care pathway for acute kidney injury management in hospital emergency admissions. NPJ Digit Med. 2019;2:67.

    Article 

    Google Scholar
     

  • Talevski J, Guerrero-Cedeno V, Demontiero O, Suriyaarachchi P, Boersma D, Vogrin S, et al. Implementation of an electronic care pathway for hip fracture patients: a pilot before and after study. BMC Musculoskelet Disord. 2020;21:837.

    Article 

    Google Scholar
     

  • Specialist LINK: A Guide to Services for Calgary and Area Physicians. Alberta Health Services; June 2020 [updated June 2020; cited July 10, 2021]; https://www.specialistlink.ca/files/SL_Teleadvice_guide_June_3_2020.pdf.

  • Arain M, Rostami M, Zaami M, Kiss V, Ward R. Specialist LINK and primary care network clinical pathways – a new approach to patient referral: a cross-sectional survey of awareness, utilization and usability among family physicians in Calgary. BMC Family Practice 2020;21.

  • Barr S, MacMullan P, Sargious M, David O. Enhanced primary care pathway: gout. alberta health services calgary zone; 2017 [updated 2017; cited April 25, 2021]; https://www.specialistlink.ca/files/Gout_Enhanced_Primary_Care_Pathway_Sept_15_2017_Final_2.pdf.

  • Graham ID, Logan J, Harrison MB, Straus SE, Tetroe J, Caswell W, et al. Lost in knowledge translation: time for a map? J Contin Educ Health Prof. 2006;26:13–24.

    Article 

    Google Scholar
     

  • Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53.

    Article 

    Google Scholar
     

  • Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.

    Article 

    Google Scholar
     

  • Waltz TJ, Powell BJ, Fernandez ME, Abadie B, Damschroder LJ. Choosing implementation strategies to address contextual barriers: diversity in recommendations and future directions. Implement Sci. 2019;14:42.

    Article 

    Google Scholar
     

  • Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol. 2012;39:1559–82.

    CAS 
    Article 

    Google Scholar
     

  • Alberta Health Services; 2014 [updated 2014; cited]; https://www.albertahealthservices.ca/ahs-map-ahs-zones.pdf.

  • Barber CE, Patel JN, Woodhouse L, Smith C, Weiss S, Homik J, et al. Development of key performance indicators to evaluate centralized intake for patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther. 2015;17:322.

    Article 

    Google Scholar
     

  • Lopatina E, Marshall DA, Barber CEH, Miller JL, Teare SR, Marlett NJ, et al. The voice of patients in system redesign: A case study of redesigning a centralized system for intake of referrals from primary care to rheumatologists for patients with suspected rheumatoid arthritis. Health Expect. 2019;22:348–63.

    Article 

    Google Scholar
     

  • Barber CEH, Lacaille D, Hall M, Bohm V, Li LC, Barnabe C, et al. Priorities for high-quality care in rheumatoid arthritis: results of patient, health professional, and policy maker perspectives. J Rheumatol 2020.

  • Barber CEH, Then KL, Bohm V, Hall M, Marshall DA, Rankin JA, et al. Development of a patient-centered quality measurement framework for measuring, monitoring, and optimizing rheumatoid arthritis care in Canada. J Rheumatol. 2021;48:326–34.

    Article 

    Google Scholar
     

  • Barber CEH, Mosher D, Dowling S, Bohm V, Solbak NM, MacMullan P, et al. Implementation and evaluation of audit and feedback for monitoring treat-to-target (T2T) strategies in rheumatoid arthritis using performance measures. Rheumatol Ther. 2020;7:909–25.

    Article 

    Google Scholar
     

  • Hazlewood GS, Barr SG, Lopatina E, Marshall DA, Lupton TL, Fritzler MJ, et al. Improving appropriate access to care with central referral and triage in rheumatology. Arthritis Care Res (Hoboken). 2016;68:1547–53.

    Article 

    Google Scholar
     

  • Services AH. Rheumatology Central Access and Triage. Alberta Health Services; 2021 [updated 2021; cited April 25, 2021]; https://albertareferraldirectory.ca/PublicSearchController?direct=displayViewServiceAtFacility&serviceAtFacilityId=1069914&pageNumberToDisplay=1&publicSearch=true.

  • Wu AH, Lewandrowski K, Gronowski AM, Grenache DG, Sokoll LJ, Magnani B. Antiquated tests within the clinical pathology laboratory. Am J Manag Care. 2010;16:e220–7.

    PubMed 

    Google Scholar
     

  • Crowson CS, Rahman MU, Matteson EL. Which measure of inflammation to use? A comparison of erythrocyte sedimentation rate and c-reactive protein measurements from randomized clinical trials of golimumab in rheumatoid arthritis. J Rheumatol. 2009;36:1606–10.

    CAS 
    Article 

    Google Scholar
     

  • HIV 2013 Critical Appraisal Report. Journal [serial on the Internet]. 2013 Date. https://canadiantaskforce.ca/wp-content/uploads/2016/05/2013-hiv-en-ca-final.pdf.

  • Menzies D, Gonzalo G.Khan, Kamran. Canadian Tuberculosis Standards 7th Edition; 2014Contract No.: Document Number|.

  • van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011;70:414–22.

    Article 

    Google Scholar
     

  • Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79:39–52.

    CAS 
    Article 

    Google Scholar
     

  • Hazlewood GS, Pardo JP, Barnabe C, Schieir O, Barber CEH, Bernatsky S, et al. Canadian rheumatology association recommendation for the use of COVID-19 vaccination for patients with autoimmune rheumatic diseases. J Rheumatol. 2021;48:1330–9.

    CAS 
    Article 

    Google Scholar
     

  • Canadian Rheumatology Association and Canadian Arthritis Patient
    Alliance. Decision Tool for the COVID-19 Vaccine in Patients with
    Autoimmune Rheumatic Diseases. 2021. Available from rheum.ca/decision-tool/.

  • Smolen JS, Aletaha D, Bijlsma JWJ, Breedveld FC, Boumpas D, Burmester G, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–7.

    Article 

    Google Scholar
     

  • Alemao E, Joo S, Kawabata H, Al MJ, Allison PD, Rutten-Van Mölken MPMH, et al. Effects of achieving target measures in rheumatoid arthritis on functional status, quality of life, and resource utilization: analysis of clinical practice data. Arthritis Care Res. 2016;68:308–17.

    CAS 
    Article 

    Google Scholar
     

  • Goekoop-Ruiterman YPM, De Vries-Bouwstra JK, Kerstens PJSM, Nielen MMJ, Vos K, Van Schaardenburg D, et al. DAS-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis. Ann Rheum Dis. 2010;69:65–9.

    CAS 
    Article 

    Google Scholar
     

  • Schipper LG, Vermeer M, Kuper HH, Hoekstra MO, Haagsma CJ, Broeder AAD, et al. A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry. Ann Rheum Dis. 2012;71:845–50.

    CAS 
    Article 

    Google Scholar
     

  • Stoffer MA, Schoels MM, Smolen JS, Aletaha D, Breedveld FC, Burmester G, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis. 2016;75:16–22.

    Article 

    Google Scholar
     

  • Soubrier M, Lukas C, Sibilia J, Fautrel B, Roux F, Gossec L, et al. Disease activity score-driven therapy versus routine care in patients with recent-onset active rheumatoid arthritis: data from the GUEPARD trial and ESPOIR cohort. Ann Rheum Dis. 2011;70:611–5.

    CAS 
    Article 

    Google Scholar
     

  • Marmor MF, Kellner U, Lai TYY, Melles RB, Mieler WF. Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 Revision). Ophthalmology. 2016;123:1386–94.

    Article 

    Google Scholar
     

  • Barber CEH, Zell J, Yazdany J, Davis AM, Cappelli L, Ehrlich-Jones L, et al. 2019 American college of rheumatology recommended patient-reported functional status assessment measures in rheumatoid arthritis. Arthritis Care Res. 2019;71:1531–9.

    Article 

    Google Scholar
     

  • England BR, Barber CEH, Bergman M, Ranganath VK, Suter LG, Michaud K. Brief Report: adaptation of american college of rheumatology rheumatoid arthritis disease activity and functional status measures for telehealth visits. Arthrit Care Res 2020.

  • Barber CEH. Rheum4U: Development and testing of a web-based tool for improving the quality of care for patients with rheumatoid arthritis. Clin Exp Rheumatol 37:385–92.

  • Advanced Clinician Practitioner in Arthritis Care (ACPAC). Advanced clinican practitioner in arthritis care (ACPAC). 2016 [updated 2016; cited 2016 January 29]; http://acpacprogram.ca/.

  • Schrijvers G, Hoorn AV, Huiskes N. The care pathway concept: concepts and theories: an introduction. Int J Integrated Care 2012;12.

  • Barber CEH, Jewett L, Badley EM, Lacaille D, Cividino A, Ahluwalia V, et al. Stand up and be counted: measuring and mapping the rheumatology workforce in Canada. J Rheumatol. 2017;44:248–57.

    Article 

    Google Scholar
     

  • Ndosi M, Lewis M, Hale C, Quinn H, Ryan S, Emery P, et al. The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial. Ann Rheum Dis. 2014;73:1975–82.

    Article 

    Google Scholar
     

  • Koksvik HS, Hagen KB, Rødevand E, Mowinckel P, Kvien TK, Zangi HA. Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides. Ann Rheum Dis. 2013;72:836–43.

    Article 

    Google Scholar
     

  • Nikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JW, Daien CI, et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheumat Dis 2021:annrheumdis-202.

  • Seys D, Coeckelberghs E, Sermeus W, Van Zelm R, Panella M, Payedimarri AB, et al. Overview on the target population and methods used in care pathway projects: a narrative review. Int J Clin Prac 2021;e14565.

  • Barber CEH, Levy D, Ahluwalia V, Mendel A, Taylor-Gjevre R, Gerschmann T, et al. Best Practices for Virtual Care, a consensus statement form the canadian rheumatology association. J Rheumatol 2021.

  • Public Health Agency of Canada. Canadian Immunization Guide; 2021. Available from: https://www.canada.ca/en/public-health/services/canadian-immunization-guide.html

  • Alberta Health Services. Alberta Immunization Schedule; 2021. Available from: https://www.alberta.ca/immunization-routine-schedule.aspx

  • Canadian Rheumatology Association. Canadian Rheumatology Association Position Statement on COVID-19 Vaccination. 2021 [updated 2021; cited 2021 October 1]; Available from: https://rheum.ca/wp-content/uploads/2021/05/v5-FINAL_Sept-27_EN_Updated-Position-Statement-on-COVID-19-Vaccination.pdf.

  • Rights and permissions

    Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

    Disclaimer:

    This article is autogenerated using RSS feeds and has not been created or edited by OA JF.

    Click here for Source link (https://www.biomedcentral.com/)

    By admin